Coherus BioSciences Ownership 2024 | Who Owns Coherus BioSciences Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

9.86%

Insider Ownership

1.39%

Retail Ownership

88.75%

Institutional Holders

47.00

Coherus BioSciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.10.42%0.00%11,752,500521,9784.65%20,331,825Jun 30, 2024
VANGUARD GROUP INC9.40%0.00%10,602,389522,8355.19%18,342,133Jun 30, 2024
RUBRIC CAPITAL MANAGEMENT LP9.22%0.47%10,400,000--17,992,000Jun 30, 2024
TEMASEK HOLDINGS (PRIVATE) LTD5.16%0.05%5,818,802-1,562,314-21.17%10,066,527Jun 30, 2024
KOHLBERG KRAVIS ROBERTS & CO. L.P.2.69%0.16%3,036,076--5,252,413Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.11%0.00%2,382,231178,5378.10%4,121,677Jun 30, 2024
BARCLAYS PLC1.94%0.00%2,190,521125,1706.06%3,790,000Jun 30, 2024
GOLDMAN SACHS GROUP INC1.92%0.00%2,160,031445,45725.98%3,736,853Jun 30, 2024
STATE STREET CORP1.79%0.00%2,012,75317,0150.85%3,482,063,000Jun 30, 2024
C WORLDWIDE GROUP HOLDING A/S1.71%0.04%1,928,464--3,336,000Jun 30, 2024
MORGAN STANLEY1.38%0.00%1,556,850-1,107,319-41.56%2,693,352Jun 30, 2024
DISCIPLINED GROWTH INVESTORS INC /MN1.11%0.04%1,257,0891,1520.09%2,174,764Jun 30, 2024
CM MANAGEMENT, LLC0.98%1.75%1,100,000100,00010.00%1,903,000Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.93%0.18%1,050,0001,050,000100.00%1,816,500Jun 30, 2024
TEJARA CAPITAL LTD0.91%0.65%1,030,386-25,000-2.37%1,782,568Jun 30, 2024
PEREGRINE CAPITAL MANAGEMENT LLC0.90%0.05%1,012,635-3,820-0.38%1,751,859Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.89%0.01%1,001,0571,001,057100.00%1,731,829Jun 30, 2024
ALPHACENTRIC ADVISORS LLC0.89%1.27%1,000,000--1,730,000Jun 30, 2024
NORTHERN TRUST CORP0.81%0.00%913,746-7,895-0.86%1,580,780,000Jun 30, 2024
MACQUARIE GROUP LTD0.80%0.00%899,999--1,557,000Jun 30, 2024

Coherus BioSciences's largest institutional shareholder is BLACKROCK INC., holding 10.42% of the company's total share outstanding, currently valued at $20.33M. The top 10 institutional shareholders own together 46.37% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CM MANAGEMENT, LLC0.98%1.75%1,100,000100,00010.00%1,903,000Jun 30, 2024
ALPHACENTRIC ADVISORS LLC0.89%1.27%1,000,000--1,730,000Jun 30, 2024
TEJARA CAPITAL LTD0.91%0.65%1,030,386-25,000-2.37%1,782,568Jun 30, 2024
RUBRIC CAPITAL MANAGEMENT LP9.22%0.47%10,400,000--17,992,000Jun 30, 2024
BIRCHVIEW CAPITAL, LP0.24%0.43%270,000--467,100Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.93%0.18%1,050,0001,050,000100.00%1,816,500Jun 30, 2024
BRIDGE CITY CAPITAL, LLC0.28%0.18%316,0096250.20%546,696Jun 30, 2024
KOHLBERG KRAVIS ROBERTS & CO. L.P.2.69%0.16%3,036,076--5,252,413Jun 30, 2024
TYCHE WEALTH PARTNERS LLC0.19%0.09%215,902--373,510Jun 30, 2024
PENNANT INVESTORS, LP0.15%0.08%168,100--290,813Jun 30, 2024
WEALTH GROUP, LTD.0.05%0.07%52,47752,477100.00%94,000Jun 30, 2024
PEREGRINE CAPITAL MANAGEMENT LLC0.90%0.05%1,012,635-3,820-0.38%1,751,859Jun 30, 2024
TEMASEK HOLDINGS (PRIVATE) LTD5.16%0.05%5,818,802-1,562,314-21.17%10,066,527Jun 30, 2024
DISCIPLINED GROWTH INVESTORS INC /MN1.11%0.04%1,257,0891,1520.09%2,174,764Jun 30, 2024
XTX TOPCO LTD0.24%0.04%271,433204,391304.87%469,579Jun 30, 2024
CLEARLINE CAPITAL LP0.70%0.04%784,449--1,357,097Jun 30, 2024
C WORLDWIDE GROUP HOLDING A/S1.71%0.04%1,928,464--3,336,000Jun 30, 2024
LEGATO CAPITAL MANAGEMENT LLC0.09%0.02%98,229--169,936Jun 30, 2024
CARR FINANCIAL GROUP CORP0.03%0.02%35,195--60,887Jun 30, 2024
SARGENT INVESTMENT GROUP, LLC0.04%0.02%43,130-5,570-11.44%74,615Jun 30, 2024

The largest Coherus BioSciences shareholder by % of total assets is CM MANAGEMENT, LLC. The company owns 1.10M shares of Coherus BioSciences (CHRS), representing 1.75% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TANG CAPITAL MANAGEMENT LLC0.93%0.18%1,050,0001,050,000100.00%1,816,500Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.89%0.01%1,001,0571,001,057100.00%1,731,829Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC0.64%0.00%719,999719,999100.00%1,245,598Jun 30, 2024
VANGUARD GROUP INC9.40%0.00%10,602,389522,8355.19%18,342,133Jun 30, 2024
BLACKROCK INC.10.42%0.00%11,752,500521,9784.65%20,331,825Jun 30, 2024
NORGES BANK0.44%0.00%491,500491,500100.00%850,295Jun 30, 2024
GOLDMAN SACHS GROUP INC1.92%0.00%2,160,031445,45725.98%3,736,853Jun 30, 2024
MARSHALL WACE, LLP0.37%0.00%420,326268,763177.33%727,163Jun 30, 2024
LAZARD ASSET MANAGEMENT LLC0.56%0.00%630,747243,04762.69%1,091,000Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.22%0.01%243,000243,000100.00%420,390Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.35%0.00%394,828242,500159.20%683,052Jun 30, 2024
XTX TOPCO LTD0.24%0.04%271,433204,391304.87%469,579Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.11%0.00%2,382,231178,5378.10%4,121,677Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.75%0.00%848,110158,98423.07%1,467,230Jun 30, 2024
BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC0.62%0.01%699,645143,70025.85%1,210,386Jun 30, 2024
BARCLAYS PLC1.94%0.00%2,190,521125,1706.06%3,790,000Jun 30, 2024
SG AMERICAS SECURITIES, LLC0.11%0.00%123,577106,052605.15%214,000Jun 30, 2024
FMR LLC0.16%-185,909100,409117.44%321,622Jun 30, 2024
CM MANAGEMENT, LLC0.98%1.75%1,100,000100,00010.00%1,903,000Jun 30, 2024
STRS OHIO0.08%0.00%94,60094,600100.00%163,658,000Jun 30, 2024

As of Jun 30 2024, Coherus BioSciences's largest institutional buyer is TANG CAPITAL MANAGEMENT LLC. The company purchased 1.05M stocks of CHRS, valued at $1.82M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BANK OF AMERICA CORP /DE/0.24%-275,095-2,152,130-88.67%475,914Jun 30, 2024
TEMASEK HOLDINGS (PRIVATE) LTD5.16%0.05%5,818,802-1,562,314-21.17%10,066,527Jun 30, 2024
MORGAN STANLEY1.38%0.00%1,556,850-1,107,319-41.56%2,693,352Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.55%0.00%616,028-641,335-51.01%1,065,728Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.74%0.00%834,241-627,772-42.94%1,443,237Jun 30, 2024
WOODLINE PARTNERS LP0.29%0.01%322,680-212,759-39.74%558,236Jun 30, 2024
JPMORGAN CHASE & CO0.05%-60,310-166,769-73.44%104,336Jun 30, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----155,036-100.00%-Jun 30, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.03%0.00%36,748-109,483-74.87%63,574Jun 30, 2024
KNOTT DAVID M JR----106,185-100.00%-Jun 30, 2024
DEUTSCHE BANK AG\0.04%-39,475-86,038-68.55%68,292Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----80,063-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.0.13%0.00%151,909-65,732-30.20%262,803,000Jun 30, 2024
RFG ADVISORY, LLC----59,210-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC0.01%-10,214-57,364-84.89%17,670Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----51,732-100.00%-Jun 30, 2024
STIFEL FINANCIAL CORP----49,925-100.00%-Jun 30, 2024
BARCLAYS PLC----49,900-100.00%-Jun 30, 2024
WALLEYE CAPITAL LLC0.03%0.00%28,137-49,299-63.66%48,677Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----41,879-100.00%-Jun 30, 2024

As of Jun 30 2024, Coherus BioSciences's biggest institutional seller is BANK OF AMERICA CORP /DE/. The company sold -2.15M shares of CHRS, valued at $475.91K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TANG CAPITAL MANAGEMENT LLC0.93%0.18%1,050,0001,050,000100.00%1,816,500Jun 30, 2024
NORGES BANK0.44%0.00%491,500491,500100.00%850,295Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.22%0.01%243,000243,000100.00%420,390Jun 30, 2024
STRS OHIO0.08%0.00%94,60094,600100.00%163,658,000Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.05%0.00%59,21859,218100.00%102,447Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.05%0.00%53,69153,691100.00%92,885Jun 30, 2024
WEALTH GROUP, LTD.0.05%0.07%52,47752,477100.00%94,000Jun 30, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.0.03%0.00%35,48135,481100.00%61,382Jun 30, 2024
SAVANT CAPITAL, LLC0.03%0.00%32,88332,883100.00%56,888Jun 30, 2024
CI PRIVATE WEALTH, LLC0.03%0.00%30,00030,000100.00%51,900Jun 30, 2024
TIAA TRUST, NATIONAL ASSOCIATION0.02%0.00%27,26127,261100.00%47,162Jun 30, 2024
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC0.01%0.00%10,16910,169100.00%17,592Jun 30, 2024
NVERSES CAPITAL, LLC0.00%0.00%4,5004,500100.00%7,785Jun 30, 2024
CWM, LLC0.00%-4,2234,223100.00%7,000Jun 30, 2024
US BANCORP \DE\0.00%-3,0013,001100.00%5,192Jun 30, 2024
SWAN CAPITAL LLC0.00%0.00%1,3001,300100.00%2,249Jun 30, 2024
ROTHSCHILD INVESTMENT LLC0.00%-6565100.00%112Jun 30, 2024

Coherus BioSciences's largest new institutional shareholder by number of shares is TANG CAPITAL MANAGEMENT LLC, purchased 1.05M shares, valued at $1.82M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----155,036-100.00%-Jun 30, 2024
KNOTT DAVID M JR----106,185-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----80,063-100.00%-Jun 30, 2024
RFG ADVISORY, LLC----59,210-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----51,732-100.00%-Jun 30, 2024
STIFEL FINANCIAL CORP----49,925-100.00%-Jun 30, 2024
BARCLAYS PLC----49,900-100.00%-Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----41,879-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----39,167-100.00%-Jun 30, 2024
ATOM INVESTORS LP----39,164-100.00%-Jun 30, 2024
TORNO CAPITAL, LLC----30,000-100.00%-Jun 30, 2024
BAYESIAN CAPITAL MANAGEMENT, LP----23,559-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----19,900-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----16,211-100.00%-Jun 30, 2024
WOLVERINE TRADING, LLC----16,100-100.00%-Jun 30, 2024
AIGEN INVESTMENT MANAGEMENT, LP----13,325-100.00%-Jun 30, 2024
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC----10,446-100.00%-Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----3,408-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----2,365-100.00%-Jun 30, 2024
POINT72 (DIFC) LTD----1,066-100.00%-Jun 30, 2024
NEWEDGE ADVISORS, LLC----300-100.00%-Jun 30, 2024
DAIWA SECURITIES GROUP INC.----262-100.00%-Jun 30, 2024
FARTHER FINANCE ADVISORS, LLC----91-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----31-100.00%-Jun 30, 2024
EAGLE BAY ADVISORS LLC----30-100.00%-Jun 30, 2024

Coherus BioSciences's largest sold out institutional shareholder by shares sold is NEW YORK LIFE INVESTMENT MANAGEMENT LLC, sold -0.16M shares, valued at -, as of undefined.

Coherus BioSciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
SCHRODER GLOBAL SERIES TRUST11.73%23,934--Jan 31, 2021
HIGHLAND FUNDS II2.50%37,000--Dec 31, 2023
Vanguard Montgomery Funds1.16%277,976--Mar 31, 2024
BANCROFT FUND LTD1.08%1,500,000-1,500,000-50.00%Dec 29, 2023
Delaware Enhanced Global Dividend & Income Fund1.07%394,000--Feb 28, 2023
ELLSWORTH GROWTH & INCOME FUND LTD1.07%1,500,000-1,500,000-50.00%Dec 29, 2023
Manager Directed Portfolios1.06%173,334--Jan 31, 2024
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC0.95%750,000-750,000-50.00%Dec 29, 2023
AB DISCOVERY GROWTH FUND, INC.0.87%1,296,872--Jan 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.77%900,000250,00038.46%Mar 28, 2024
DELAWARE GROUP EQUITY FUNDS IV0.68%790,000--Mar 28, 2024
DELAWARE INVESTMENTS DIVIDEND & INCOME FUND, INC0.62%163,000--Feb 28, 2023
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.59%543,726--Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.58%111,923--Mar 28, 2024
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC0.56%445,000--Dec 29, 2023
ELLSWORTH GROWTH & INCOME FUND LTD0.52%735,000--Dec 29, 2023
BANCROFT FUND LTD0.48%665,000--Dec 29, 2023
NUVEEN INVESTMENT TRUST0.44%245,199--Mar 31, 2024
UBS RELATIONSHIP FUNDS0.41%98,000--Jun 30, 2020
TETON WESTWOOD FUNDS0.39%255,000--Dec 29, 2023
SYNTAX ETF TRUST0.28%8,833--Mar 31, 2024
ROYCE CAPITAL FUND0.21%79,312--Mar 31, 2024
TEKLA LIFE SCIENCES INVESTORS0.16%76,742--Mar 31, 2024
ALGER FUNDS0.16%155,763--Jan 31, 2024
TETON WESTWOOD FUNDS0.15%100,000-250,000-71.43%Dec 29, 2023
TEKLA HEALTHCARE INVESTORS0.15%126,361--Mar 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.14%167,000--Mar 28, 2024
VANGUARD EXPLORER FUND0.14%1,693,303--Jan 31, 2024
ROYCE VALUE TRUST, INC.0.13%106,700--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.12%65,031--Mar 31, 2024
DSS AMERICAFIRST QUANTITATIVE FUNDS0.12%2,793--Dec 29, 2023
VANGUARD ADMIRAL FUNDS0.09%409,073--Feb 29, 2024
VANGUARD HORIZON FUNDS0.09%2,031,209-944,707-31.75%Mar 31, 2024
Voya EQUITY TRUST0.08%121,437--Feb 29, 2024
BNY MELLON INDEX FUNDS, INC.0.08%89,063--Jan 31, 2024
Delaware Enhanced Global Dividend & Income Fund0.08%29,000--Feb 28, 2023
BNY MELLON INVESTMENT PORTFOLIOS0.06%37,785--Mar 31, 2024
AB CAP FUND, INC.0.06%2,083,865--Jan 31, 2024
SunAmerica Specialty Series0.05%27,061-2,203-7.53%Apr 30, 2021
DELAWARE GROUP EQUITY FUNDS V0.05%2,828,000--Feb 29, 2024
Humankind Benefit Corp0.04%937--Dec 31, 2023
BNY Mellon Strategic Funds, Inc.0.04%94,665--Mar 31, 2024
DELAWARE INVESTMENTS DIVIDEND & INCOME FUND, INC0.04%10,000--Feb 28, 2023
360 Funds0.03%7,2141,78332.83%Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.03%179,604--Mar 31, 2024
STATE STREET INSTITUTIONAL FUNDS0.03%20,875--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%14,337--Mar 31, 2024
OBERWEIS FUNDS0.02%22,300--Mar 31, 2024
PFM Multi-Manager Series Trust0.02%17,260--Dec 31, 2023
IndexIQ ETF Trust0.02%46,697-4,191-8.24%Jan 31, 2024
PAX WORLD FUNDS SERIES TRUST I0.02%365,248--Mar 31, 2024
FIDELITY MT VERNON STREET TRUST0.02%469,916--Feb 29, 2024
DELAWARE VIP TRUST0.02%57,000-58,000-50.43%Mar 28, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.02%36,075--Mar 31, 2024
Vericimetry Funds0.01%1,330--Mar 31, 2024
Bernstein Fund Inc0.01%122,049--Mar 31, 2024
VALUED ADVISERS TRUST0.01%10,902--Jan 31, 2024
AMG Funds I0.01%23,101--Jan 31, 2024
VANGUARD INDEX FUNDS0.01%4,716,260-1,320,772-21.88%Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.01%41,837--Jan 31, 2024
FRONTIER FUNDS, INC.0.01%4,125--Mar 31, 2024
Columbia Funds Variable Series Trust II0.01%315,826--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,173--Mar 31, 2024
Fidelity Commonwealth Trust II0.01%61,882--Aug 31, 2023
Brown Advisory Funds0.01%292,762--Mar 31, 2024
NEXPOINT FUNDS I0.01%30,000--Dec 31, 2023
Nushares ETF Trust0.01%57,274--Jan 31, 2024
FIDELITY SECURITIES FUND0.01%715,928--Jan 31, 2024
VANGUARD QUANTITATIVE FUNDS0.01%36,300--Mar 31, 2024
JNL VARIABLE FUND LLC0.01%40,328--Mar 31, 2020
FIDELITY COMMONWEALTH TRUST0.01%22,605--Feb 29, 2024
AB VARIABLE PRODUCTS SERIES FUND, INC.0.01%29,773--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.01%78,7686990.90%Mar 31, 2024
SCHWAB CAPITAL TRUST0.01%265,690--Jan 31, 2024
ALPS ETF Trust0.01%74,812--Feb 29, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.01%24,484--Mar 31, 2024
AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS)0.01%194,716--Jan 31, 2024
EXCHANGE TRADED CONCEPTS TRUST0.01%31,299--Feb 29, 2024
TIAA-CREF LIFE FUNDS0.01%14,910--Mar 31, 2024
BlackRock ETF Trust0.01%4,842--Jan 31, 2024
CARILLON SERIES TRUST0.01%286,262--Mar 31, 2024
LORD ABBETT SECURITIES TRUST0.00%22,659--Jan 31, 2024
ETF Managers Trust0.00%36,690--Dec 31, 2023
Direxion Shares ETF Trust0.00%688,137--Jan 31, 2024
Lattice Strategies Trust0.00%6,832--Mar 31, 2024
ROYCE FUND0.00%28,887--Mar 31, 2024
HUSSMAN INVESTMENT TRUST0.00%15,600--Dec 31, 2023
SSGA FUNDS0.00%1,890--Feb 29, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%223,627-56,281-20.11%Mar 31, 2024
World Funds Trust0.00%52,658--Jan 31, 2024
NUVEEN INVESTMENT FUNDS INC0.00%143,875--Jan 31, 2024
DELAWARE VIP TRUST0.00%14,000--Mar 28, 2024
Calvert Variable Products, Inc.0.00%9,819--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND IV0.00%798,000--Jan 31, 2024
MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC0.00%1,8781,878-Sep 30, 2020
VALIC Co II0.00%99,0743,1023.23%Feb 28, 2021
VANGUARD TAX-MANAGED FUNDS0.00%566,307--Mar 31, 2024
SHELTON FUNDS0.00%4,320--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%530,290-336,298-38.81%Feb 29, 2024
PRAXIS MUTUAL FUNDS0.00%28,080--Dec 31, 2023

Coherus BioSciences's largest mutual fund holder by % of total assets is "SCHRODER GLOBAL SERIES TRUST", owning 23.93K shares, compromising 11.73% of its total assets.

Coherus BioSciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2447-67.36%
31 Mar, 24144-11.11%
31 Dec, 23162-6.36%
30 Sep, 231733.59%
30 Jun, 23167-0.60%
31 Mar, 23168-1.75%
31 Dec, 22171-
30 Sep, 22171-2.84%
30 Jun, 22176-1.68%
31 Mar, 22179-8.21%
31 Dec, 211951.56%
30 Sep, 21192-1.54%
30 Jun, 21195-7.14%
31 Mar, 212107.14%
31 Dec, 20196-3.92%
30 Sep, 202046.25%
30 Jun, 20192-1.54%
31 Mar, 20195-
31 Dec, 1919512.07%
30 Sep, 1917415.23%
30 Jun, 1915124.79%
31 Mar, 191216.14%
31 Dec, 18114-1.72%
30 Sep, 18116-9.38%
30 Jun, 1812817.43%
31 Mar, 181096.86%
31 Dec, 17102-
30 Sep, 17102-17.07%
30 Jun, 171232.50%
31 Mar, 17120-7.69%
31 Dec, 161304.00%
30 Sep, 1612540.45%
30 Jun, 168917.11%
31 Mar, 1676-2.56%
31 Dec, 1578-1.27%
30 Sep, 15793.95%
30 Jun, 157652.00%
31 Mar, 155031.58%
31 Dec, 1438-

As of 30 Jun 24, 47 institutions are holding Coherus BioSciences's shares, representing a decrease of -67.36% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2411,120,059-86.38%
31 Mar, 2481,648,5630.42%
31 Dec, 2381,306,136-12.52%
30 Sep, 2392,943,5547.17%
30 Jun, 2386,721,37310.68%
31 Mar, 2378,355,585-0.25%
31 Dec, 2278,548,3051.52%
30 Sep, 2277,368,519-1.95%
30 Jun, 2278,905,3924.47%
31 Mar, 2275,529,575-0.49%
31 Dec, 2175,898,2620.63%
30 Sep, 2175,423,924-1.98%
30 Jun, 2176,944,242-3.13%
31 Mar, 2179,429,891-8.43%
31 Dec, 2086,746,6691.34%
30 Sep, 2085,599,924-1.05%
30 Jun, 2086,510,92615.90%
31 Mar, 2074,641,7892.88%
31 Dec, 1972,555,5134.84%
30 Sep, 1969,206,1273.86%
30 Jun, 1966,632,354-3.15%
31 Mar, 1968,803,0224.74%
31 Dec, 1865,688,0813.27%
30 Sep, 1863,605,7732.67%
30 Jun, 1861,953,51712.05%
31 Mar, 1855,290,12311.72%
31 Dec, 1749,490,3805.46%
30 Sep, 1746,928,92616.89%
30 Jun, 1740,149,4856.85%
31 Mar, 1737,574,04625.57%
31 Dec, 1629,921,9796.32%
30 Sep, 1628,142,83411.14%
30 Jun, 1625,322,01738.87%
31 Mar, 1618,234,7239.04%
31 Dec, 1516,722,254-26.78%
30 Sep, 1522,838,45251.64%
30 Jun, 1515,061,051107.21%
31 Mar, 157,268,447-26.21%
31 Dec, 149,850,154-

Coherus BioSciences (CHRS) has 11.12M shares outstanding as of 30 Jun 24, down -86.38% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 249.86%0.13%
31 Mar, 2486.71%1.25%
31 Dec, 2383.19%0.73%
30 Sep, 23106.50%0.89%
30 Jun, 23109.40%1.12%
31 Mar, 2398.85%0.97%
31 Dec, 22101.18%1.02%
30 Sep, 2299.51%0.96%
30 Jun, 22101.74%1.06%
31 Mar, 2297.77%0.97%
31 Dec, 21100.59%1.10%
30 Sep, 2195.46%0.92%
30 Jun, 21101.83%0.86%
31 Mar, 21109.06%0.74%
31 Dec, 20121.47%0.85%
30 Sep, 20119.47%0.81%
30 Jun, 20121.68%1.09%
31 Mar, 20105.63%0.99%
31 Dec, 19103.34%1.05%
30 Sep, 1999.04%1.08%
30 Jun, 1995.90%0.97%
31 Mar, 1999.51%1.07%
31 Dec, 1896.47%1.10%
30 Sep, 1893.75%1.00%
30 Jun, 1896.86%1.15%
31 Mar, 1891.96%1.06%
31 Dec, 1793.14%1.24%
30 Sep, 1786.79%1.42%
30 Jun, 1778.28%1.32%
31 Mar, 1777.14%1.51%
31 Dec, 1671.39%1.70%
30 Sep, 1664.74%1.67%
30 Jun, 1662.22%2.86%
31 Mar, 1646.64%2.53%
31 Dec, 1542.95%1.22%
30 Sep, 1559.43%3.72%
30 Jun, 1539.98%8.43%
31 Mar, 1521.78%0.88%
31 Dec, 1449.64%-

As of 30 Jun 24, Coherus BioSciences is held by 9.86% institutional shareholders, representing a 0.13% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2425-58.33%
31 Mar, 2460-25.00%
31 Dec, 2380-23.08%
30 Sep, 231047.22%
30 Jun, 239742.65%
31 Mar, 2368-18.07%
31 Dec, 2283-6.74%
30 Sep, 2289-7.29%
30 Jun, 229621.52%
31 Mar, 2279-5.95%
31 Dec, 218412.00%
30 Sep, 2175-26.47%
30 Jun, 21102-8.11%
31 Mar, 2111123.33%
31 Dec, 2090-20.35%
30 Sep, 20113-2.59%
30 Jun, 2011618.37%
31 Mar, 2098-16.95%
31 Dec, 1911819.19%
30 Sep, 199913.79%
30 Jun, 198731.82%
31 Mar, 19668.20%
31 Dec, 18615.17%
30 Sep, 1858-21.62%
30 Jun, 187423.33%
31 Mar, 186017.65%
31 Dec, 1751-
30 Sep, 1751-30.14%
30 Jun, 1773-2.67%
31 Mar, 17758.70%
31 Dec, 1669-13.75%
30 Sep, 168021.21%
30 Jun, 166643.48%
31 Mar, 1646-
31 Dec, 1546-2.13%
30 Sep, 1547-25.40%
30 Jun, 156370.27%
31 Mar, 1537-2.63%
31 Dec, 1438-

25 institutional shareholders have increased their position in CHRS stock as of 30 Jun 24 compared to 60 in the previous quarter (a -58.33% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 249-83.33%
31 Mar, 2454-3.57%
31 Dec, 235621.74%
30 Sep, 23466.98%
30 Jun, 2343-33.85%
31 Mar, 236518.18%
31 Dec, 2255-5.17%
30 Sep, 22589.43%
30 Jun, 2253-22.06%
31 Mar, 2268-9.33%
31 Dec, 2175-1.32%
30 Sep, 217631.03%
30 Jun, 2158-12.12%
31 Mar, 2166-5.71%
31 Dec, 207011.11%
30 Sep, 206314.55%
30 Jun, 2055-17.91%
31 Mar, 206745.65%
31 Dec, 19466.98%
30 Sep, 19434.88%
30 Jun, 194128.13%
31 Mar, 1932-3.03%
31 Dec, 1833-15.38%
30 Sep, 183939.29%
30 Jun, 1828-6.67%
31 Mar, 18303.45%
31 Dec, 172916.00%
30 Sep, 17258.70%
30 Jun, 1723-11.54%
31 Mar, 1726-31.58%
31 Dec, 163872.73%
30 Sep, 1622100.00%
30 Jun, 1611-35.29%
31 Mar, 1617-26.09%
31 Dec, 15239.52%
30 Sep, 1521200.00%
30 Jun, 157-30.00%
31 Mar, 1510-
31 Dec, 14--

9 institutional shareholders have reduced their position in CHRS stock as of 30 Jun 24 compared to 54 in the previous quarter (a -83.33% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2447-67.36%11,120,059-86.38%9.86%0.13%25-58.33%9-83.33%
31 Mar, 24144-11.11%81,648,5630.42%86.71%1.25%60-25.00%54-3.57%
31 Dec, 23162-6.36%81,306,136-12.52%83.19%0.73%80-23.08%5621.74%
30 Sep, 231733.59%92,943,5547.17%106.50%0.89%1047.22%466.98%
30 Jun, 23167-0.60%86,721,37310.68%109.40%1.12%9742.65%43-33.85%
31 Mar, 23168-1.75%78,355,585-0.25%98.85%0.97%68-18.07%6518.18%
31 Dec, 22171-78,548,3051.52%101.18%1.02%83-6.74%55-5.17%
30 Sep, 22171-2.84%77,368,519-1.95%99.51%0.96%89-7.29%589.43%
30 Jun, 22176-1.68%78,905,3924.47%101.74%1.06%9621.52%53-22.06%
31 Mar, 22179-8.21%75,529,575-0.49%97.77%0.97%79-5.95%68-9.33%
31 Dec, 211951.56%75,898,2620.63%100.59%1.10%8412.00%75-1.32%
30 Sep, 21192-1.54%75,423,924-1.98%95.46%0.92%75-26.47%7631.03%
30 Jun, 21195-7.14%76,944,242-3.13%101.83%0.86%102-8.11%58-12.12%
31 Mar, 212107.14%79,429,891-8.43%109.06%0.74%11123.33%66-5.71%
31 Dec, 20196-3.92%86,746,6691.34%121.47%0.85%90-20.35%7011.11%
30 Sep, 202046.25%85,599,924-1.05%119.47%0.81%113-2.59%6314.55%
30 Jun, 20192-1.54%86,510,92615.90%121.68%1.09%11618.37%55-17.91%
31 Mar, 20195-74,641,7892.88%105.63%0.99%98-16.95%6745.65%
31 Dec, 1919512.07%72,555,5134.84%103.34%1.05%11819.19%466.98%
30 Sep, 1917415.23%69,206,1273.86%99.04%1.08%9913.79%434.88%
30 Jun, 1915124.79%66,632,354-3.15%95.90%0.97%8731.82%4128.13%
31 Mar, 191216.14%68,803,0224.74%99.51%1.07%668.20%32-3.03%
31 Dec, 18114-1.72%65,688,0813.27%96.47%1.10%615.17%33-15.38%
30 Sep, 18116-9.38%63,605,7732.67%93.75%1.00%58-21.62%3939.29%
30 Jun, 1812817.43%61,953,51712.05%96.86%1.15%7423.33%28-6.67%
31 Mar, 181096.86%55,290,12311.72%91.96%1.06%6017.65%303.45%
31 Dec, 17102-49,490,3805.46%93.14%1.24%51-2916.00%
30 Sep, 17102-17.07%46,928,92616.89%86.79%1.42%51-30.14%258.70%
30 Jun, 171232.50%40,149,4856.85%78.28%1.32%73-2.67%23-11.54%
31 Mar, 17120-7.69%37,574,04625.57%77.14%1.51%758.70%26-31.58%
31 Dec, 161304.00%29,921,9796.32%71.39%1.70%69-13.75%3872.73%
30 Sep, 1612540.45%28,142,83411.14%64.74%1.67%8021.21%22100.00%
30 Jun, 168917.11%25,322,01738.87%62.22%2.86%6643.48%11-35.29%
31 Mar, 1676-2.56%18,234,7239.04%46.64%2.53%46-17-26.09%
31 Dec, 1578-1.27%16,722,254-26.78%42.95%1.22%46-2.13%239.52%
30 Sep, 15793.95%22,838,45251.64%59.43%3.72%47-25.40%21200.00%
30 Jun, 157652.00%15,061,051107.21%39.98%8.43%6370.27%7-30.00%
31 Mar, 155031.58%7,268,447-26.21%21.78%0.88%37-2.63%10-
31 Dec, 1438-9,850,154-49.64%-38---

Coherus BioSciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 15, 2024Wahlstrom Matsdirector-G-GiftSell99,988---
Feb 05, 2024Wahlstrom Matsdirector-M-ExemptSell44,991$1.67$75.00K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 09, 2024McMichael Bryan Jofficer Chief Financial OfficerA-AwardBuy75,000$1.24$93.00K75,000
Jul 24, 2024Lanfear Dennis Mdirector, officer President & CEOA-AwardBuy196,500$2.41$473.56K196,500
Jul 24, 2024Reider Paulofficer Chief Commercial OfficerA-AwardBuy40,000$2.41$96.40K40,000
Jun 05, 2024Karachun Rita Adirector-A-AwardBuy168,000$1.78$299.04K168,000
Jun 05, 2024Karachun Rita A-Buy----
Jun 05, 2024Erbez Georgiadirector-A-AwardBuy114,000$1.78$202.92K114,000
Jun 05, 2024Newton Charles W.director-A-AwardBuy112,000$1.76$197.12K112,000
Jun 05, 2024Ryan Michael Leedirector-A-AwardBuy112,000$1.76$197.12K112,000
Jun 05, 2024Wahlstrom Matsdirector-A-AwardBuy112,000$1.76$197.12K112,000
Jun 05, 2024STOLPER MARKdirector-A-AwardBuy112,000$1.76$197.12K112,000
Jun 05, 2024Newcomer Lee Nisleydirector-A-AwardBuy112,000$1.76$197.12K112,000
Jun 05, 2024TZOUMAKAS KIMBERLY JOdirector-A-AwardBuy112,000$1.76$197.12K112,000
Jun 05, 2024O'Donnell-Tormey Jilldirector-A-AwardBuy112,000$1.76$197.12K112,000
Feb 22, 2024Erbez Georgiadirector-A-AwardBuy54,000$2.59$139.86K54,000
Feb 22, 2024Erbez Georgia-Buy----
Feb 15, 2024Wahlstrom Matsdirector-G-GiftBuy99,988--99,988
Feb 15, 2024Wahlstrom Matsdirector-G-GiftSell99,988---
Feb 05, 2024Wahlstrom Matsdirector-M-ExemptBuy44,991$1.67$75.00K99,988
Feb 05, 2024Wahlstrom Matsdirector-M-ExemptBuy14,997$1.67$25.00K54,997
Feb 05, 2024Wahlstrom Matsdirector-M-ExemptSell44,991$1.67$75.00K-

The last insider sell of Coherus BioSciences's stock was made by Wahlstrom Mats on Feb 15 2024, selling 99,988 shares at - per share (valued at -).

Coherus BioSciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20243--
Q2 20249--
Q1 20247887.50%
Q4 20232450.00%
Q3 20231--
Q2 2023102500.00%
Q1 202391275.00%
Q4 2022-1-
Q3 20221--
Q2 202222100.00%
Q1 2022182900.00%
Q4 2021-2-
Q3 20212366.67%
Q2 202193300.00%
Q1 20212522113.64%
Q4 2020142751.85%
Q3 2020101283.33%
Q2 202061346.15%
Q1 20202723117.39%
Q4 201951533.33%

3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Coherus BioSciences's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024---
Q1 2024---
Q4 2023-1-
Q3 2023---
Q2 2023---
Q1 2023---
Q4 2022---
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021-1-
Q3 2021-3-
Q2 202111100.00%
Q1 2021-8-
Q4 2020-13-
Q3 2020-3-
Q2 2020-7-
Q1 2020-10-
Q4 2019-9-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Coherus BioSciences's stocks.

Coherus BioSciences Peer Ownership


TickerCompany
GRCLGracell Biotechnologies Inc.
NUVBNuvation Bio Inc.
ACHLAchilles Therapeutics plc
NXTCNextCure, Inc.
CTMXCytomX Therapeutics, Inc.
SPROSpero Therapeutics, Inc.
BOLTBolt Biotherapeutics, Inc.
ASMBAssembly Biosciences, Inc.
NLTXNeurogene Inc.
TILInstil Bio, Inc.

CHRS Ownership FAQ


Coherus BioSciences is owned by institutional shareholders (9.86%), insiders (1.39%), and public (88.75%). The largest institutional shareholder of Coherus BioSciences is BLACKROCK INC. (10.42% of total shares) and the top mutual fund owner is SCHRODER GLOBAL SERIES TRUST (11.73% of total shares).

Coherus BioSciences's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, RUBRIC CAPITAL MANAGEMENT LP, TEMASEK HOLDINGS (PRIVATE) LTD, and KOHLBERG KRAVIS ROBERTS & CO. L.P.. The top five shareholders own together 36.90% of the company's share outstanding.

As of Jun 2024, there are 47 institutional shareholders of Coherus BioSciences.

BLACKROCK INC owns 11.75M shares of Coherus BioSciences, representing 10.42% of the company's total shares outstanding, valued at $20.33M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 10.6M shares of Coherus BioSciences (CHRS), compromising 9.40% of the company, valued at $18.34M.

RUBRIC CAPITAL MANAGEMENT LP is the third largest holder of Coherus BioSciences. The company owns 10.4M of the company's shares outstanding (worth $17.99M).